These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15313160

  • 1. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
    Kitamura Y, Okumura K, Imamura A, Mizuno T, Tsuzuki M, Numaguchi Y, Matsui H, Murohara T.
    Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
    [Abstract] [Full Text] [Related]

  • 2. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 3. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 4. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 5. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [Abstract] [Full Text] [Related]

  • 6. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N.
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 May; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S, Estellés A, Tormo G, Falco C, Gilabert J, España F, Cano A, Segui R, Aznar J.
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Feb 01; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 11. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar 01; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 12. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G, Berdeli A, Gürkan A, Han Saygan B, Köse T, Atilla G.
    J Clin Periodontol; 2007 Apr 01; 34(4):278-84. PubMed ID: 17257155
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H, Wallmark K, Jern S, Karlsson L.
    Thromb Res; 2008 Apr 01; 121(6):793-7. PubMed ID: 17884148
    [Abstract] [Full Text] [Related]

  • 14. Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters.
    Ruiz-Quezada S, Vázquez-Del Mercado M, Parra-Rojas I, Rangel-Villalobos H, Best-Aguilera C, Sánchez-Orozco LV, Muñoz-Valle JF.
    Ann Genet; 2004 Apr 01; 47(2):155-62. PubMed ID: 15183748
    [Abstract] [Full Text] [Related]

  • 15. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
    Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W.
    Thromb Haemost; 1999 Sep 01; 82(3):1121-6. PubMed ID: 10494775
    [Abstract] [Full Text] [Related]

  • 16. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR.
    Thromb Haemost; 1999 Jul 01; 82(1):115-20. PubMed ID: 10456464
    [Abstract] [Full Text] [Related]

  • 17. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
    Song Y, Xu W, Chen Y, Che L, Wang Q, Zhou X, Wu J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec 01; 16(6):374-6. PubMed ID: 10581347
    [Abstract] [Full Text] [Related]

  • 18. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE, Lane A, Dawson S, Green FR.
    Arch Pathol Lab Med; 1992 Dec 01; 116(12):1322-9. PubMed ID: 1456879
    [Abstract] [Full Text] [Related]

  • 19. [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].
    Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr 01; 21(2):173-5. PubMed ID: 15079805
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Apr 01; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.